Yihang Qi

机构：Beth Israel Deaconess Medical Center, Harvard University, Hadassah Medical Center, China University of Petroleum, East China · ORCID：0000-0001-7589-0333

发表论文 50 篇 · 总被引 889 次 · h-index 17

代表论文

• Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer (2023 · Progress in Materials Science · 被引 153)
• Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples (2021 · Frontiers in Immunology · 被引 45)
• Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy (2022 · Frontiers in Nutrition · 被引 34)
• PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism (2022 · Frontiers in Pharmacology · 被引 27)
• O-GlcNAcylation in tumorigenesis and its implications for cancer therapy (2024 · Journal of Biological Chemistry · 被引 25)
• Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence (2021 · Frontiers in Pharmacology · 被引 25)